
Demis Hassabis and John Jumper
Demis Hassabis: Co-founder and CEO, Google DeepMind; John Jumper: Director, Google DeepMind


Demis Hassabis and John Jumper are the developers behind AlphaFold, an algorithmic model that can predict the 3D shape of proteins from their amino acid sequences. The model lets researchers visualize and study the interactions between proteins more readily than ever before. AlphaFold has advanced efforts to better understand the causes of heart disease, develop a malaria vaccine, and address the threat of antimicrobial resistance, among many other applications. Hassabis and Jumper were awarded the 2024 Nobel Prize in chemistry for their achievements.
From STAT:
2024 Nobel Prize in chemistry: Three scientists win for groundbreaking work in proteins
In fundamental advance, Google says AlphaFold 3 can map a vast universe of biomolecules
Industry
Location
London, U.K.
Advertisement
More inBusiness

Business
Mark Cuban
Co-founder, Cost Plus Drugs

Business
Judy Faulkner
Founder and CEO, Epic Systems Corporation

Business
Omar Lateef
President and CEO, Rush University System for Health

Business
John Link
Scientific adviser, Actio Biosciences and Terremoto Bio

Business
Bob Nelsen
Co-founder and managing director, ARCH Venture Partners

Business
David Ricks
Chair and CEO, Eli Lilly and Company

Business
Jaewon Ryu
CEO, Risant Health

Business
Andrew Witty
CEO, UnitedHealth Group

Business
Michelle Xia
Founder and CEO, Akeso Biopharma

Business
Daphne Zohar
Founder and CEO, Seaport Therapeutics

Fifty influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech
View the List
